Buphenine Explained
Buphenine (or nylidrin; trade name Arlidin) is a β2 adrenoreceptor agonist[1] that acts as a vasodilator.[2]
It was developed as a chemical derivative of oxilofrine, and first reported in the literature in 1950.[3]
See also
Notes and References
- Mittag TW, Tormay A, Messenger M, Podos SM . Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin . Invest Ophthalmol Vis Sci . 26 . 2 . 163–9 . February 1985 . 2857689 . dead . https://archive.today/20130415011509/http://www.iovs.org/cgi/pmidlookup?view=long&pmid=2857689 . 2013-04-15 .
- Freedman L. Arlidin: a new vasodilative sympathomimetic drug . Angiology . 1955 . 6 . 1 . 52–8 . 14350296 . 10.1177/000331975500600106. 46317963 .
- Külz F, Schneider M. Über neue gefäßerweiternde Sympathomimetika . German . On new vasodilative sympathomimetics . Klin Wochenschr . 1950 . 28 . 31–32 . 535–7. 10.1007/BF01481535 . 14775050 .